000			01552 a2200397 4500
005			20250513113930.0
264		0	_c19970609
008			199706s 0 0 eng d
022			_a0047-6374
024	7		_a10.1016/s0047-6374(96)01809-x _2doi
040			_aNLM _beng _cNLM
100	1		_aPowers, D C
245	0	0	_aSummary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults. _h[electronic resource]
260			_bMechanisms of ageing and development _cFeb 1997
300			_a179-88 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdjuvants, Immunologic
650	0	4	_aAged
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aAntibody Formation
650	0	4	_aCytotoxicity, Immunologic
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Carriers
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aHemagglutination Inhibition Tests
650	0	4	_aHumans
650	0	4	_aImmunoglobulin A _xblood
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aInfluenza A virus _ximmunology
650	0	4	_aInfluenza Vaccines _xadverse effects
650	0	4	_aInfluenza, Human _ximmunology
650	0	4	_aLiposomes
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
773	0		_tMechanisms of ageing and development _gvol. 93 _gno. 1-3 _gp. 179-88
856	4	0	_uhttps://doi.org/10.1016/s0047-6374(96)01809-x _zAvailable from publisher's website
999			_c9073219 _d9073219